Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 14, 2023

SELL
$5.72 - $8.8 $200 - $308
-35 Reduced 18.92%
150 $1.2 Million
Q1 2023

May 17, 2023

SELL
$6.28 - $9.85 $628 - $985
-100 Reduced 35.09%
185 $1.5 Million
Q4 2022

Jan 31, 2023

SELL
$6.09 - $7.93 $138,577 - $180,447
-22,755 Reduced 98.76%
285 $1,000
Q3 2022

Nov 09, 2022

SELL
$4.58 - $9.21 $76,142 - $153,116
-16,625 Reduced 41.91%
23,040 $158,000
Q2 2022

Jul 15, 2022

SELL
$7.06 - $23.63 $42,360 - $141,780
-6,000 Reduced 13.14%
39,665 $331,000
Q1 2022

Apr 25, 2022

BUY
$21.6 - $27.79 $94,500 - $121,581
4,375 Added 10.6%
45,665 $1.04 Million
Q4 2021

Feb 15, 2022

SELL
$23.0 - $29.01 $3,450 - $4,351
-150 Reduced 0.36%
41,290 $1.14 Million
Q2 2021

Jul 28, 2021

SELL
$27.43 - $32.7 $110,405 - $131,617
-4,025 Reduced 8.85%
41,440 $1.22 Million
Q1 2021

Apr 14, 2021

SELL
$21.37 - $34.38 $97,874 - $157,460
-4,580 Reduced 9.15%
45,465 $1.44 Million
Q4 2020

Jan 15, 2021

SELL
$15.31 - $21.12 $6,889 - $9,504
-450 Reduced 0.89%
50,045 $1.04 Million
Q3 2020

Oct 14, 2020

BUY
$14.88 - $20.13 $175,807 - $237,835
11,815 Added 30.55%
50,495 $784,000
Q2 2020

Jul 21, 2020

SELL
$13.31 - $20.51 $9,982 - $15,382
-750 Reduced 1.9%
38,680 $707,000
Q1 2020

Apr 16, 2020

BUY
$12.98 - $30.25 $314,180 - $732,201
24,205 Added 158.98%
39,430 $611,000
Q2 2019

Jul 24, 2019

BUY
$20.52 - $26.45 $63,099 - $81,333
3,075 Added 25.31%
15,225 $383,000
Q4 2018

Feb 05, 2019

BUY
$17.64 - $28.32 $201,713 - $323,839
11,435 Added 1599.3%
12,150 $224,000
Q3 2018

Nov 08, 2018

BUY
$20.64 - $25.67 $14,757 - $18,354
715 New
715 $55.6 Million

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.23B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Westside Investment Management, Inc. Portfolio

Follow Westside Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Westside Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Westside Investment Management, Inc. with notifications on news.